^
    No biomarker
    Hairy Cell Leukemia
    cladribine
    Sensitive
    :
    A1
    No biomarker
    Hairy Cell Leukemia
    moxetumomab pasudotox
    Sensitive
    :
    A1
    No biomarker
    Hairy Cell Leukemia
    rituximab
    Sensitive
    :
    A2
    No biomarker
    Hairy Cell Leukemia
    rituximab
    Sensitive
    :
    A2
    No biomarker
    Hairy Cell Leukemia
    vemurafenib + rituximab
    Sensitive
    :
    A2
    No biomarker
    Hairy Cell Leukemia
    pentostatin
    Sensitive
    :
    A2
    No biomarker
    Hairy Cell Leukemia
    rituximab/hyaluronidase
    Sensitive
    :
    A2
    No biomarker
    Hairy Cell Leukemia
    rituximab
    Sensitive
    :
    A2
    No biomarker
    Hairy Cell Leukemia
    vemurafenib
    Sensitive
    :
    A2
    No biomarker
    Hairy Cell Leukemia
    ibrutinib
    Sensitive
    :
    A2
    BRAF V600E
    Hairy Cell Leukemia
    dabrafenib
    Sensitive
    :
    C1
    BRAF V600
    Hairy Cell Leukemia
    vemurafenib
    Sensitive
    :
    C1
    BRAF V600E
    Hairy Cell Leukemia
    vemurafenib
    Sensitive
    :
    C1
    BRAF V600E
    Hairy Cell Leukemia
    dabrafenib + rituximab
    Sensitive
    :
    C3
    MYD88 L265P + BRAF V600E
    Hairy Cell Leukemia
    rituximab
    Sensitive
    :
    C4
    KRAS mutation
    Hairy Cell Leukemia
    vemurafenib
    Resistant
    :
    C4
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES